ArticleMultiple sclerosis and related disorders2021

Clinical impact of Ocrelizumab extended interval dosing during the COVID-19 pandemic and associations with CD19

Nitin Kumar Sahi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.